ArticleFrontiers in immunology2026

Efficacy of combined modality conversion therapy for HCC with portal vein tumor thrombus: a retrospective cohort study.

Jian Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.